课题基金 / 基金详情

Productive role of fractalkine and CXCL16 in human epidermal keratinocytes

Productive role of fractalkine and CXCL16 in human epidermal keratinocytes
fractalkine 和 CXCL16 在人表皮角质形成细胞中的生产作用
批准号:
16591103
负责人:
TOHYAMA Mikiko
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

TOHYAMA Mikiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
CXCL16 is a ligand for CXCR6, a CXC-chemokine receptor. CXCL16 is synthesized as a membrane-bound form that is cleaved to a soluble form that is a chemoattractant for CXCR6-expressing cells such as activated CD8 T cells, NKT cells, and Th1-polarized CD4 and CD8 T cells. By contrast, a membrane-bound form of CXCL16 expressed on human macrophages and dendritic cells acts as a scavenger receptor for oxidized low density lipoprotein. In addition, CXCL16 expressed on macrophages mediates adhesion and phagocytosis of bacteria such as Escheria coli or Staphylococcus aureus. The soluble chemokine domain of CXCL16 at concentrations > 5 □g/ml had antimicrobial activity against S.aureus and E.coli. Addition of 10 □g/ml soluble CXCL16 reduced the survival rate of S.aureus and E.coli by 70 and 40%, respectively. Because CXCL16 is produced constitutively by HEK, CXCL16 contributes to host-defense function in relation to microbial pathogens in human skin as well as □-defensins.Fractalkine/CX3CL1, a chemokine, is synthesized as a membrane bound form and converted to a soluble form by protease(s). Since fractalkine recruits CX3CR1 positive cells such as NK cells and CD8+ T cells, it is supposed to be involved in recruiting these cells into the epidermis in the inflammatory reaction. To address this issue, we investigated whether normal human keratinocytes can produce fractalkine in the presence of cytokines. TNF-□, IL1-□□ and IFN-□ synergistically enhanced IFN-□-induced fractalkine production in normal human keratinocytes. In conclusion, this is the first report showing that normal human keratinocytes produce soluble fractalkine protein.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.jdermsci.2005.12.011
发表时间: 2006-05
期刊: Journal of dermatological science
影响因子: 4.6
作者: [Lujun Yang;K. Yamasaki;Y. Shirakata;X. Dai;S. Tokumaru;Y. Yahata;M. Tohyama;Y. Hanakawa;K. Sayama;K. Hashimoto]
通讯作者: Lujun Yang;K. Yamasaki;Y. Shirakata;X. Dai;S. Tokumaru;Y. Yahata;M. Tohyama;Y. Hanakawa;K. Sayama;K. Hashimoto
DOI: 10.1038/sj.jid.5700294
发表时间: 2006-07-01
期刊: JOURNAL OF INVESTIGATIVE DERMATOLOGY
影响因子: 6.5
作者: [Dai, Xiuju, Sayama, Koji, Hashimoto, Koji]
通讯作者: Hashimoto, Koji
DOI: 10.1016/j.bbrc.2004.11.145
发表时间: 2005-02-04
期刊: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子: 3.1
作者: [Tokumaru, S, Sayama, K, Hashimoto, K]
通讯作者: Hashimoto, K
TGF-beta is not involved in early phase growth inhibition of keratinocytes by lalpha, 25(OH)2vitamin D3
TGF-β 不参与 lalpha、25(OH)2 维生素 D3 对角质形成细胞的早期生长抑制
DOI: --
发表时间: 2004
期刊: J Dermatol Sci 36
影响因子: --
作者: [Shirakawa Y, Ueno H, Hanakawa Y, et al.]
通讯作者: et al.
12
    Development of living skin equivalent models over-expressing IL-22R on epidermal keratinocytes
    • 批准号:
      22591241
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2010
    • 负责人:
      TOHYAMA Mikiko
    • 依托单位:
    国内基金
    海外基金
    Fractalkine通过靶向调节小胶质细胞CD163/SHH表达促进脑出血后血肿吸收和神经血管修复的研究
    • 批准号:
      82071335
    • 项目类别:
      面上项目
    • 资助金额:
      55.0万元
    • 批准年份:
      2020
    • 负责人:
      贺权威
    • 依托单位:
    mTOR调节巨噬细胞极化在Fractalkine介导的慢性间歇低氧所致肝损伤中的作用及分子机制
    • 批准号:
      2020JJ4812
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      王轶娜
    • 依托单位:
    Fractalkine/CX3CR1轴介导羊膜腔注射的骨髓间充质干细胞向胎鼠显性脊柱裂靶向迁移促进神经功能修复的研究
    • 批准号:
      82001643
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2020
    • 负责人:
      马巍
    • 依托单位:
    结核分枝杆菌Hsp16.3通过Fractalkine/CX3CR1信号轴调控巨噬细胞M2型极化的作用机制
    • 批准号:
      81860291
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      35.0万元
    • 批准年份:
      2018
    • 负责人:
      罗军敏
    • 依托单位: